Jean‐Claude Lepert

722 citations
27 papers · 608 indexed · h-index 12
Topics
Peroxisome Proliferator-Activated Receptors (6 papers)Drug Transport and Resistance Mechanisms (3 papers)Eicosanoids and Hypertension Pharmacology (3 papers)

In The Last Decade

Jean‐Claude Lepert

27 papers receiving 593 citations

Peers

Jean‐Claude Lepert
Comparison fields: 5 of 89
  • Molecular Biology 223
  • Immunology 183
  • Pulmonary and Respiratory Medicine 109
  • Epidemiology 97
  • Pharmacology 57
Replace Dajing Xia with:
Dajing Xia China
Zeyuan Lu China
Hang Sun China
H. Hiraishi Japan
Xiaobin Mei China
Tatsuomi Yasaka Japan
Yutaka Isozaki Japan
H.M.J. Roelofs Netherlands
P. Bonvicini Italy
Jean‐Claude Lepert relative to Dajing Xia China Dajing Xia's profile →
Citations per field
00.5×1.5×2.0×
Dajing Xia · 1×
Citations per year

Countries citing papers authored by Jean‐Claude Lepert

Since Specialization
Citations

This map shows the geographic impact of Jean‐Claude Lepert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Lepert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Lepert more than expected).

Fields of papers citing papers by Jean‐Claude Lepert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Claude Lepert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Lepert. The network helps show where Jean‐Claude Lepert may publish in the future.

Co-authorship network of co-authors of Jean‐Claude Lepert

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Lepert. A scholar is included among the top collaborators of Jean‐Claude Lepert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Lepert. Jean‐Claude Lepert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 78
2 7
3 37
4 83
5 5
6 48
7 2
8 34
9 27
10 131
11 1
12 10
13 5
14 13
15 13
16 11
17 19
18 21
19 3
20 7

About Jean‐Claude Lepert

Jean‐Claude Lepert is a scholar working on Nephrology, Biochemistry and Process Chemistry and Technology, having authored 27 papers that have together received 608 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Immunology (183 citations), Hepatology (52 citations) and Pharmacology (57 citations). Jean‐Claude Lepert has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Claudine Orfila, Bernard Pipy, Claudie Cambon, Maryse Béraud, J. M. Suc, G. Carrera, Matt Carré, Laurent Alric, J. Rami and Agnès Coste. Their work appears in journals such as Immunity, The Journal of Immunology and The Science of The Total Environment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026